Sovipostobart | Interleukin Related interleukin-related.com

Product Name :
Sovipostobart

Search keywords :
Sovipostobart

drugId :
null

Target Vo:
Cytotoxic T-Lymphocyte-Associated Antigen 4

Target Vo Short Name :
CTLA4

Moa_Name:
Anti-CTLA4

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cytomx Therapeutics Inc

Active Company_Name :
Bristol-Myers Squibb Company

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STING Rabbit pAb In Vitro
Nestin Antibody Biological Activity
KLF4 Antibody (YA716): KLF4 Antibody (YA716) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to KLF4 (3B3). It can be used for WB assays with tag free, in the background of Transfected.

Author: Interleukin Related

Related Posts